CompletedPhase 1NCT02478281

Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults

Studying Autosomal recessive methemoglobinemia

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: American Regent, Inc.
Principal Investigator: Fareeda Hosein, MD, M.D
Celerion
Intervention: Methylene Blue(drug)
Enrollment: 12 enrolled
Eligibility: 18-60 years · All sexes
Timeline: 2012 – 2013

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02478281 on ClinicalTrials.gov

← Back to all trials